Photothermal catalysis driven by defect-engineered Mn-doped V 2 O 5 for efficient rhodamine B degradation
Dalton Transactions · 2026 · 55 (19) · 7633-7640
DOI: 10.1039/d6dt00590j ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2026. Verfasst von Xiaoxia Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Energy and Materials, Shanghai Polytechnic University, Shanghai, 201209, China. wuzihua@sspu.edu.cn. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
A series of Mn-modified V 2 O 5 catalysts was synthesized via a facile sol–gel method, and their photothermal catalytic performance was systematically investigated for the degradation of Rhodamine B (RhB).
Autor:innen und Institutionen
- School of Energy and Materials, Shanghai Polytechnic University, Shanghai, 201209, China. wuzihua@sspu.edu.cn.
- Shanghai Hongli Purification Technology Co., Ltd, 7, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
Zitieren
APA
Zhou, X., Fan, J., Zhou, Z., Yu, X., Song, Z., Wu, Z., & Xie, H. (2026). Photothermal catalysis driven by defect-engineered Mn-doped V 2 O 5 for efficient rhodamine B degradation. Dalton Transactions, 55(19), 7633-7640. https://doi.org/10.1039/d6dt00590j
Vancouver
Zhou X, Fan J, Zhou Z, Yu X, Song Z, Wu Z, et al. Photothermal catalysis driven by defect-engineered Mn-doped V 2 O 5 for efficient rhodamine B degradation. Dalton Transactions. 2026;55(19):7633-7640. doi:10.1039/d6dt00590j
BibTeX
@article{Zhou2026,
author = {Zhou, Xiaoxia and Fan, Jixing and Zhou, Zhiming and Yu, Xiaoxiao and Song, Zhili and Wu, Zihua and Xie, Huaqing},
title = {Photothermal catalysis driven by defect-engineered Mn-doped V 2 O 5 for efficient rhodamine B degradation},
journal = {Dalton Transactions},
year = {2026},
volume = {55},
number = {19},
pages = {7633--7640},
doi = {10.1039/d6dt00590j}
}
EUVIMED